Omen AI raised $31 million in Series A funding to develop technology that monitors chip coolant and prevents bacterial contamination in data centers.
The startup's platform addresses a critical pain point for hyperscale data center operators: managing coolant systems and preventing microbial growth that can degrade cooling efficiency and damage equipment.
Data centers consume enormous amounts of energy for cooling infrastructure. Bacterial biofilms can form in coolant loops, reducing thermal conductivity and forcing operators to replace fluids more frequently. Omen AI's monitoring system detects early signs of contamination, enabling preventative maintenance.
The funding round positions Omen AI to expand its sensor network and analytics capabilities as major cloud providers increasingly adopt advanced cooling solutions like immersion cooling and liquid cooling to handle higher chip densities and power consumption.
Data center operators face mounting pressure to improve efficiency amid growing electricity demands from AI workloads. Water usage and energy costs in cooling represent significant operational expenses, making optimization technologies attractive to major infrastructure operators.
Retro, a friend-focused photo-sharing app founded by former Instagram employees, has secured $21 million in Series A funding. The capital injection signals investor confidence in the social app's differentiated approach to photo sharing.
Sweden has built one of Europe's most vibrant startup ecosystems, drawing attention from investors and entrepreneurs across the continent. Cherry Ventures general partner Sophia Bendz breaks down the factors driving the Nordic nation's tech boom.
Metriport secured $26M in Series A and seed funding led by Matrix GP, bringing its total funding to $28.4M. The startup provides tools that enable doctors to retrieve and manage patient data.
Faro, an AI platform for clinical trial optimization, closed a $37.3 million Series B round co-led by Merck Global Health Innovation Fund and S32. The funding will support development of data models and AI tools designed to streamline trial processes.